Skip to main content
Erschienen in: Supportive Care in Cancer 7/2008

01.07.2008 | Original Article

Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study

verfasst von: Catherine Weber, Thierry Merminod, François R. Herrmann, Gilbert B. Zulian

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Goals

The objective of this study was to determine utility of prophylactic anti-coagulation in cancer patients hospitalised for palliative care in a specialised centre.

Materials and methods

Prospective 1:1 open randomised study was designed. Twenty patients aged 55 to 88 years with advanced cancer and an estimated life expectancy of less than 6 months were assigned to either receive treatment with 2,850/3,800 U (<70/>70 kg) of daily subcutaneous nadroparin or no treatment. Suspicion of venous thrombo-embolism (deep vein thrombosis and pulmonary embolism) was confirmed by echo-Doppler examination of the lower limbs and/or by spiral computed tomography scan of the lungs. Bleeding episodes were recorded. Platelet count was measured on days 7 and 14. Survival time from study entry was determined.

Main results

One venous thrombo-embolism and one major bleeding occurred in the group receiving nadroparin, whereas two minor bleedings occurred in the control group. At 3 months, nine of ten participants had died in the control group vs five of ten in the group receiving nadroparin (P = 0.141). Five participants could be discharged home (P = 0.141).

Conclusions

Decision to administer prophylactic nadroparin in hospitalised cancer patients under palliative care remains a challenge. Better mobility score at admission and the likelihood to be discharged home may be useful for practical purposes. The observation of a potential influence of prophylactic nadroparin on survival deserves further studies.
Literatur
1.
Zurück zum Zitat Agrawal M, Danis M (2002) End-of-life care for terminally ill participants in clinical research. J Palliat Med 5:729–737PubMedCrossRef Agrawal M, Danis M (2002) End-of-life care for terminally ill participants in clinical research. J Palliat Med 5:729–737PubMedCrossRef
2.
Zurück zum Zitat Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M (1998) Venous thromboembolism and cancer. Lancet 351:1077–1080PubMedCrossRef Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M (1998) Venous thromboembolism and cancer. Lancet 351:1077–1080PubMedCrossRef
3.
Zurück zum Zitat Bruera E, Neumann CM (1998) Management of specific symptom complexes in patients receiving palliative care. Can Med Assoc J 158:1717–1726 Bruera E, Neumann CM (1998) Management of specific symptom complexes in patients receiving palliative care. Can Med Assoc J 158:1717–1726
4.
Zurück zum Zitat Bruera E, Miller L, McCallion J, Macmillan J et al (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7:192–195PubMedCrossRef Bruera E, Miller L, McCallion J, Macmillan J et al (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7:192–195PubMedCrossRef
5.
Zurück zum Zitat Casarett DJ, Karlawish JHT (2000) Are special ethical guidelines needed for palliative care research? J Pain Symptom Manage 20:130–139PubMedCrossRef Casarett DJ, Karlawish JHT (2000) Are special ethical guidelines needed for palliative care research? J Pain Symptom Manage 20:130–139PubMedCrossRef
6.
Zurück zum Zitat Deitcher SR, Gomes MP (2004) The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review. Cancer 101:439–449PubMedCrossRef Deitcher SR, Gomes MP (2004) The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review. Cancer 101:439–449PubMedCrossRef
8.
Zurück zum Zitat Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
9.
Zurück zum Zitat Goodnough LT, Saito H, Manni A, Jones PK, Pearson OH (1984) Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer 54:1264–1268PubMedCrossRef Goodnough LT, Saito H, Manni A, Jones PK, Pearson OH (1984) Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer 54:1264–1268PubMedCrossRef
10.
Zurück zum Zitat Gouin-Thibaut I, Samama MM (2000) Venous thrombosis and cancer. Ann Biol Clin (Paris) 58:675–682 Gouin-Thibaut I, Samama MM (2000) Venous thrombosis and cancer. Ann Biol Clin (Paris) 58:675–682
11.
Zurück zum Zitat Hawryluck L (2004) People at the end of life are a vulnerable research population. Clin Oncol 16:225–226CrossRef Hawryluck L (2004) People at the end of life are a vulnerable research population. Clin Oncol 16:225–226CrossRef
12.
Zurück zum Zitat Jacobs LG (2003) Prophylactic anticoagulation for venous thromboembolic disease in geriatric patients. J Am Geriatr Soc 51:1472–1478PubMedCrossRef Jacobs LG (2003) Prophylactic anticoagulation for venous thromboembolic disease in geriatric patients. J Am Geriatr Soc 51:1472–1478PubMedCrossRef
13.
Zurück zum Zitat Jilma B, Kamath S, Lip GYH (2003) Antithrombotic therapy in special circumstances. II-in children, thrombophilia, and miscellanaous conditions. Br Med J 326:93–96CrossRef Jilma B, Kamath S, Lip GYH (2003) Antithrombotic therapy in special circumstances. II-in children, thrombophilia, and miscellanaous conditions. Br Med J 326:93–96CrossRef
14.
Zurück zum Zitat Johnson MJ, Sherry K (1997) How do palliative physicians manage venous thromboembolism? Palliat Med 11:462–468PubMedCrossRef Johnson MJ, Sherry K (1997) How do palliative physicians manage venous thromboembolism? Palliat Med 11:462–468PubMedCrossRef
15.
Zurück zum Zitat Kakkar AK, Levine MN, Kadziola Z et al (2004) Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced malignancy Outcome Study (FAMOUS). J Clin Oncol 22:1944–1948PubMedCrossRef Kakkar AK, Levine MN, Kadziola Z et al (2004) Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced malignancy Outcome Study (FAMOUS). J Clin Oncol 22:1944–1948PubMedCrossRef
16.
Zurück zum Zitat Keith RA, Granger CV, Hamilton BB, Sherwin FS (1987) The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1:6–18PubMed Keith RA, Granger CV, Hamilton BB, Sherwin FS (1987) The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1:6–18PubMed
17.
Zurück zum Zitat Klerk CPW, Smorenburg SM, Otten HM et al (2005) The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23:2130–2135PubMedCrossRef Klerk CPW, Smorenburg SM, Otten HM et al (2005) The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23:2130–2135PubMedCrossRef
18.
Zurück zum Zitat Koedoot CG, de Haan RJ, Stiggelbout AM et al (2003) Palliative chemotherapy or best supportive care? A prospective study explaining patients’ preference and choice. Br J Cancer 89:2219–2226PubMedCrossRef Koedoot CG, de Haan RJ, Stiggelbout AM et al (2003) Palliative chemotherapy or best supportive care? A prospective study explaining patients’ preference and choice. Br J Cancer 89:2219–2226PubMedCrossRef
19.
Zurück zum Zitat Lee AYY (2003) Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res 110:167–172PubMedCrossRef Lee AYY (2003) Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res 110:167–172PubMedCrossRef
20.
Zurück zum Zitat Leizorovicz A, Cohen AT, Turpie AGG et al (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110:874–879PubMedCrossRef Leizorovicz A, Cohen AT, Turpie AGG et al (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110:874–879PubMedCrossRef
21.
Zurück zum Zitat Mazzocato C, Sweeney C, Bruera E (2001) Clinical research in palliative care: choice of trial design. Palliat Med 15:261–264PubMedCrossRef Mazzocato C, Sweeney C, Bruera E (2001) Clinical research in palliative care: choice of trial design. Palliat Med 15:261–264PubMedCrossRef
22.
Zurück zum Zitat Merminod T, Zulian GB (2007) Venous thromboembolism in cancer patients under palliative care: retrospective study with lessons to the future. Supportive Palliative Cancer Care J (in press) Merminod T, Zulian GB (2007) Venous thromboembolism in cancer patients under palliative care: retrospective study with lessons to the future. Supportive Palliative Cancer Care J (in press)
23.
Zurück zum Zitat Pautex S, Moynier K, Weber C, Zulian GB (2002) L’évaluation des symptômes en oncologie palliative. Méd Hyg 60:1313–1317 Pautex S, Moynier K, Weber C, Zulian GB (2002) L’évaluation des symptômes en oncologie palliative. Méd Hyg 60:1313–1317
24.
Zurück zum Zitat Samama MM, Cohen AT, Darmon JY et al (1999) A comparaison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. New Eng J Med 341:793–800PubMedCrossRef Samama MM, Cohen AT, Darmon JY et al (1999) A comparaison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. New Eng J Med 341:793–800PubMedCrossRef
25.
Zurück zum Zitat Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286–294PubMed Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286–294PubMed
26.
Zurück zum Zitat Trousseau A (1865) Phlegmasia Alba Dolens. Clinique médicale de l’Hôtel Dieu de Paris, vol 3. The New Sydenham Society, London, p 94 Trousseau A (1865) Phlegmasia Alba Dolens. Clinique médicale de l’Hôtel Dieu de Paris, vol 3. The New Sydenham Society, London, p 94
27.
Zurück zum Zitat Wilson CB, Lambert HE, Scott RD (1987) Subclavian and axillary vein thrombosis following radiotherapy for carcinoma of the breast. Clin Radiol 38:95–96PubMedCrossRef Wilson CB, Lambert HE, Scott RD (1987) Subclavian and axillary vein thrombosis following radiotherapy for carcinoma of the breast. Clin Radiol 38:95–96PubMedCrossRef
29.
Zurück zum Zitat Yancik R (2005) Population aging and cancer: a cross-national concern. Cancer 11:437–441CrossRef Yancik R (2005) Population aging and cancer: a cross-national concern. Cancer 11:437–441CrossRef
Metadaten
Titel
Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study
verfasst von
Catherine Weber
Thierry Merminod
François R. Herrmann
Gilbert B. Zulian
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2008
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0339-3

Weitere Artikel der Ausgabe 7/2008

Supportive Care in Cancer 7/2008 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.